Clinician's Roundtable

Host: Gary Kohn, MD

Guest: Levi Garraway, MD, PhD

Levi Garraway, MD, PhD, of the Dana Farber Cancer Institute in Boston, is credited with facilitating major advances in our understanding of cancer biology. He discusses the new paradigm of cancer, as a genomic disease which leads to abnormal activation of oncogenes and inactivation of suppressor genes. The implications for therapy, as we match genetic understanding to drugs, may well be revolutionary. Dr. Gary Kohn hosts.

Host: Gary Kohn, MD

Guest: Levi Garraway, MD, PhD

Levi Garraway, MD, PhD, recent recipient of the NIH Director’s New Innovator Award and assistant professor of medicine at the Harvard Medical School, has been credited with major advances in cancer biology. Dr. Garraway joins host Dr. Gary Kohn to discuss several common myths within our understanding of cancer biology and therapy.

Host: Gary Kohn, MD

Guest: Suzanne Cannegieter

Dr. Suzanne Cannegieter, Director of Clinical Epidemiology at Leiden University in the Netherlands, discusses her team's work with the international Wright Project focusing on connections between air travel and venous thrombosis.

Host: Gary Kohn, MD

Guest: Suzanne Cannegieter

Dr. Suzanne Cannegieter, director of clinical epidemiology, and the lead international researcher for the Wright Project, from Leiden University Medical Center in the Netherlands, talks about the history of research on deep venous thrombosis and extensive air travel.

Host: Larry Kaskel, MD

Guest: Charles Potter, PhD

Join Host Dr. Larry Kaskel interview Dr. Charlie Potter, CEO and inventor Glide Solid Dose Injector, WSJ innovative product runner up award winner in 2007. They will discuss the impact of a needle free delivery on distribution of immunizations, delivery of diabetic drugs and other exciting applications.

Host: Larry Kaskel, MD

Guest: Charles Potter, PhD

Needle-Free injection systems were being used to immunize large numbers of individuals after WWII. Did these needle-free systems, called ‘Jet Injectors’ actually work? If so, why has it taken us so long to develop a needle-free injection system that is a viable drug delivery tool today? Join host Dr. Larry Kaskel interviewing Charles Potter, CEO of Glide Pharmaceuticals, about the Glide Solid Dose Injector, a WSJ innovation runner up in 2007.

Host: Paul Raeburn

Guest: Kristin Harper

The first recorded outbreak of syphilis occurred in Naples, Italy in 1495. Controversy has raged over the source of the pathogen, but a recent study suggests that when Columbus discovered the New World, he also discovered syphilis. The evidence comes from an updated treponemal family tree published in PLoS. How did investigators collar Columbus? And how good is their evidence?

Host: Shira Johnson, MD

Guest: Benjamin Horne, PhD

Guest: Brent Muhlestein, MD

Dr Shira Johnson interviews Dr Benjamin Horne and Dr Brent Muhlestein from Intermountain Medical Center in Utah to discuss the practical implications of fasting on CV disease as studied in the Mormon population.

Host: Shira Johnson, MD

Guest: Benjamin Horne, PhD

Guest: Brent Muhlestein, MD

Dr Benjamin Horne and Dr Brent Muhlestein from the Intermountain Medical Center in Utah discuss their recent research into the beneficial effects of fasting on cardiovascular risk.

Host: Bill Rutenberg, MD

Guest: Dale MaGee, MD

What is the value of physician ranking in the overall discussion of improving healthcare in the United States? How can standards be developed that are acceptable to both insurance companies and healthcare providers? Is the answer a governing body to develop national standards? In this segment, Dr. Dale Magee, President of the Massachusetts Medical Society talks with host Dr. Bill Rutenberg about some of the work being done in Massachusetts and New York related to physician ranking and also shares his views on overall quality improvement.